PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pulpdent Corporation

Pulpdent Corporation reported $193,956.22 across General Payments, Research, and Ownership to 159 physicians and teaching hospitals across 161 transactions.

$194.0K
All-tracks total
161
Transactions
159
Recipients
+$25.7K
General Payments vs PY2023

Pulpdent Corporation reported $193,956.22 across all CMS Open Payments tracks (General + Research + Ownership) to 159 physicians and teaching hospitals in Program Year 2024 - ranking #1011 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $79,956.22, averaging $1.2K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer pulpdent-corporation Pulpdent Corporation

$194.0K · #1011/1,925 · 0.0% industry · PY2024

  • TOT $194.0K
  • RANK #1011
  • SHARE 0.0%
  • TXN 161
  • RCP 159
  • CAT 2
  • GEN $80.0K
  • ΔGEN +$25.7K
  • TOP1 17.5%
  • PY 2024

Nearest volume peer: NanoFuse Biologics LLC ($193.9K)

Channel Medsystems, Inc.$194.3KMedicem Inc.$194.1KPulpdent Corporation (this)$194.0KNanoFuse Biologics LLC$193.9KCarestream Health, Inc.$193.5K
All-tracks payment totals near Pulpdent Corporation (CMS Open Payments PY2024)

Pulpdent Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Pulpdent Corporation's CMS-reported General Payments increased by $25.7K (+47.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: PULPDENT CORPORATIONPY2023: PULPDENT CORPORATIONPY2024: PULPDENT CORPORATION. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$54.2KPY2024$80.0K
PY2023
$54,222.59
PY2024
$79,956.22

What the Data Shows for Pulpdent Corporation

$193,956.22: that is what Pulpdent Corporation reported in payments to 159 physicians and teaching hospitals during Program Year 2024, spread across 161 transactions ($1.2K per transaction, $1.2K per recipient). The company sits at rank #1011 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $71.9K across 44 transactions, 89.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Pulpdent Corporation's 2-category general-payment breakdown at $71.9K, 89.9% of the reported total.

How Pulpdent Corporation divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$71.9K2. Food and Beverage$8.1K
Payment Type Amount Transactions
Consulting Fee $71.9K 44
Food and Beverage $8.1K 115

Recipient Concentration in General Payments

The five largest recipient relationships account for $57,350.00 (71.7%) of $79,956.22 in this company's General Payments records across 124 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pulpdent Corporation

The five named recipients with the highest reported General Payments from this company

Howard Glazer Mr$14.0KTodd Snyder Mr$13.5KNathaniel Lawson Mr$12.0KAnthony Stefanou Mr$9.6KBrittany Warren Bergeron Ms$8.3K
  1. 1

    Howard Glazer Mr

    $14,000.00 across 7 reported transactions

  2. 2

    Todd Snyder Mr

    $13,500.00 across 7 reported transactions

  3. 3

    Nathaniel Lawson Mr

    $12,000.00 across 12 reported transactions

  4. 4

    Anthony Stefanou Mr

    $9,600.00 across 2 reported transactions

  5. 5

    Brittany Warren Bergeron Ms

    $8,250.00 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Pulpdent Corporation's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pulpdent Corporation.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Pulpdent Corporation.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Pulpdent Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.